Helping Children Receive an Earlier Autism Diagnosis

For ParentsFor Providers

Earlier Diagnosis + Earlier Intervention = Better Outcomes

A NEW DIAGNOSTIC TOOL

Our NPDX ASD test may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

Learn More
Earlier access to specialty care and treatments improve outcomes

Posters & Publications

Posters

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Metabolism-Based Diagnosis and Precision Medicine for Autism Spectrum Disorders [National TACA Autism Conference – East Coast 2019]

Presented at the National TACA Autism Conference – East Coast in Atlanta, Georgia; March 2019. We conducted the Children’s Autism Metabolome Project (CAMP), the largest clinical study to date of the metabolism of children with autism spectrum disorder (ASD). Utilizing our proprietary analysis methods to analyze the metabolism of these 1,100 children, ages 18-48 months,[…]

Read more

Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Metabolism-Based Diagnosis and Precision Medicine for Autism Spectrum Disorders [National TACA Autism Conference – East Coast 2019]

Presented at the National TACA Autism Conference – East Coast in Atlanta, Georgia; March 2019. We conducted the Children’s Autism Metabolome Project (CAMP), the largest clinical study to date of the metabolism of children with autism spectrum disorder (ASD). Utilizing our proprietary analysis methods to analyze the metabolism of these 1,100 children, ages 18-48 months,[…]

Read more

NEWS

Metabolism-Based Diagnosis and Precision Medicine for Autism Spectrum Disorders [National TACA Autism Conference – East Coast 2019]

Presented at the National TACA Autism Conference – East Coast in Atlanta, Georgia; March 2019. We conducted the Children’s Autism Metabolome Project (CAMP), the largest clinical study to date of the metabolism of children with autism spectrum disorder (ASD). Utilizing our proprietary analysis methods to analyze the metabolism of these 1,100 children, ages 18-48 months,[…]

Read more

How can I get the NPDX ASD test now?

How to Order

You can find more information in our FAQs.

Parents FAQs
Providers FAQs

Read our paper, published in Biology Psychiatry, which details the results of our clinical study.

Publication: September 2018

© 2019 NeuroPointDX All rights reserved. CLIA #: 52D2122420

Powered by Stemina Biomarker Discovery